The HPS6 Knockout A-549 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population targeting the HPS6 gene in human A-549 cells. This loss-of-function model enables investigation of HPS6, a subunit of the BLOC-2 complex essential for lysosome-related organelle biogenesis. The polyclonal format yields a heterogeneous edited pool, suitable for pooled functional studies without clonal bias. This product facilitates mechanistic dissection of HPS6-dependent trafficking and organelle formation.
The A-549 host cell line is a well-characterized model of lung adenocarcinoma, derived from the explanted tumor tissue of a 58-year-old male. It retains features of alveolar type II epithelial cells and is widely used in pulmonary disease research. This background is particularly relevant for Hermansky-Pudlak syndrome studies, as HPS patients often develop pulmonary fibrosis. Integrating HPS6 knockout into A-549 cells allows researchers to examine epithelial cell-autonomous consequences of BLOC-2 deficiency in a lung-relevant context.
HPS6 operates within the BLOC-2 complex, interacting with HPS3, HPS5, and the AP-3 adaptor, while engaging clathrin and the Rab32/38 GTPases to sort and traffic cargo such as TYR, TYRP1, DCT, LAMP1, and CD63 to melanosomes, lysosomes, and platelet dense granules. Expression of the complex is modulated by the MIT/TFE transcription factors MITF, TFEB, and TFE3, which are activated by lysosomal stress. Knockout of HPS6 therefore disrupts the delivery of these downstream targets, impairing maturation of lysosome-related organelles and altering associated degradative and secretory pathways.
In A-549 cells, HPS6 disruption leads to lysosomal dysfunction and defective autophagy, characterized by reduced clearance of autophagic substrates and altered LC3 processing. This recapitulates cellular hallmarks of HPS6-deficiency and provides a platform to study pulmonary complications such as alveolar epithelial injury and fibrosis. Additionally, the compromised lysosomal system in these cancer cells offers opportunities to explore autophagy-dependent survival mechanisms under nutrient or oxidative stress, linking organelle trafficking to tumor biology.
These polyclonal knockout cells support diverse research utilities, including Hermansky-Pudlak syndrome type 6 modeling, analysis of lysosome-related organelle biogenesis, pulmonary fibrosis investigation, and drug screening for lysosomal disorders. Commonly employed assays include Western blotting for HPS6 and LAMP1, RT-qPCR, immunofluorescence for LAMP1 and LC3, Lysotracker staining, autophagy flux measurements, co-immunoprecipitation of BLOC-2 subunits, and RNA-seq. For further technical inquiries, please contact Ascent Research.
